Matsumoto Taro, Bohman Svante, Dixelius Johan, Berge Tone, Dimberg Anna, Magnusson Peetra, Wang Ling, Wikner Charlotte, Qi Jian Hua, Wernstedt Christer, Wu Jiong, Bruheim Skjalg, Mugishima Hideo, Mukhopadhyay Debrabata, Spurkland Anne, Claesson-Welsh Lena
Rudbeck Laboratory, Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden.
EMBO J. 2005 Jul 6;24(13):2342-53. doi: 10.1038/sj.emboj.7600709. Epub 2005 Jun 16.
Vascular endothelial growth factor receptor-2 (VEGFR-2) activation by VEGF-A is essential in vasculogenesis and angiogenesis. We have generated a pan-phosphorylation site map of VEGFR-2 and identified one major tyrosine phosphorylation site in the kinase insert (Y951), in addition to two major sites in the C-terminal tail (Y1175 and Y1214). In developing vessels, phosphorylation of Y1175 and Y1214 was detected in all VEGFR-2-expressing endothelial cells, whereas phosphorylation of Y951 was identified in a subset of vessels. Phosphorylated Y951 bound the T-cell-specific adapter (TSAd), which was expressed in tumor vessels. Mutation of Y951 to F and introduction of phosphorylated Y951 peptide or TSAd siRNA into endothelial cells blocked VEGF-A-induced actin stress fibers and migration, but not mitogenesis. Tumor vascularization and growth was reduced in TSAd-deficient mice, indicating a critical role of Y951-TSAd signaling in pathological angiogenesis.
血管内皮生长因子A(VEGF-A)激活血管内皮生长因子受体2(VEGFR-2)在血管发生和血管生成过程中至关重要。我们绘制了VEGFR-2的全磷酸化位点图谱,并确定了激酶插入区的一个主要酪氨酸磷酸化位点(Y951),以及C末端尾巴的两个主要位点(Y1175和Y1214)。在发育中的血管中,在所有表达VEGFR-2的内皮细胞中均检测到Y1175和Y1214的磷酸化,而在一部分血管中鉴定出Y951的磷酸化。磷酸化的Y951与肿瘤血管中表达的T细胞特异性衔接蛋白(TSAd)结合。将Y951突变为F,并向内皮细胞中引入磷酸化的Y951肽或TSAd小干扰RNA(siRNA),可阻断VEGF-A诱导的肌动蛋白应激纤维形成和迁移,但不影响有丝分裂。TSAd缺陷小鼠的肿瘤血管生成和生长减少,表明Y951-TSAd信号在病理性血管生成中起关键作用。